Spero Therapeutics, Inc.: Evercore ISI Raises Its Buy Recommendation







Marketzone with MT Newswires 2022

All the news about SPERO THERAPEUTICS, INC.

Analyst Recommendations for SPERO THERAPEUTICS, INC.

2022 turnover 10.8M
–
11.0M
2022 net result -80.7M
–
-82.2M
Net debt 2022 –
–
–
PER 2022-0.91x
2022 return–
Capitalization 28.8M
28.8M
29.4M
capi. / CA 20222.66x
capi. / CA 20237.86x
Number of employees41
Floating84.2%

Chart SPERO THERAPEUTICS, INC.


Hard :

Period:




Spero Therapeutics, Inc. : Spero Therapeutics, Inc. Technical Analysis Chart | Market area

Trends Technical Analysis SPERO THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsbullishNeutralBearish

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts4
Last Closing Price$2.20
Average price target$4.67
Deviation / Average Target112%

Officers and Directors




Source link -88